What is the best treatment in the next few years to achieve more treatment-free remission in CML?
Why do charities need to keep funding research into leukemia and blood cancer in general?
ABL001 – a new BCR-ABL inhibitor for chronic myeloid leukemia (CML) treatment
Choosing treatment options for CLL and combining novel drugs
COMy 2017: Day 2 discussion on relapsed myeloma, treatment, plasma cell leukemia and awards
Arnon Nagler et al.